Literature DB >> 6363176

The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man.

W K Waldhäusl, S Gasić, P Bratusch-Marrain, P Nowotny.   

Abstract

To determine the effect of the 75 g oral glucose tolerance test on carbohydrate and lipid metabolism, the splanchnic exchange of glucose, lactate, pyruvate, non-esterified fatty acids, beta-hydroxybutyrate and acetoacetate as well as the release of insulin, C-peptide, glucagon and pancreatic polypeptide were evaluated in eight healthy male volunteers in the basal state and for 150 min following glucose ingestion. Oral glucose loading was followed by a rapid rise in splanchnic output of glucose (mean +/- SEM; 154 +/- 12 mmol/150 min), pyruvate (1.2 +/- 1.2 mmol/150 min) and lactate (8.6 +/- 2.0 mmol/150 min), whereas there were reductions in the splanchnic uptake of non-esterified fatty acids (-10.7 +/- 4.4 mmol/150 min) and the splanchnic output of beta-hydroxybutyrate (-4.8 +/- 3.3 mmol/150 min) and acetoacetate (-3.0 +/- 1.2 mmol/150 min). In parallel, splanchnic output of insulin (12.3 +/- 2.7 nmol/150 min), C-peptide (36.1 +/- 5.0 nmol/150 min) and transiently of pancreatic polypeptide rose, whereas that of glucagon fell (-0.58 +/- 0.21 nmol/150 min). Even at 150 min after glucose ingestion, splanchnic output and arterial concentrations of glucose, lactate, insulin and C-peptide were still above their respective basal values while those of non-esterified fatty acids and glucagon were reduced. Taking into account the partial suppression of endogenous glucose production by ingested glucose it is concluded that, in normal postabsortive man, only 49-63% of a 75 g oral glucose load is retained by the splanchnic bed during the first 150 min, the rest being available for non-hepatic tissues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363176     DOI: 10.1007/bf00284457

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  INHIBITION BY INSULIN OF HEPATIC GLUCOSE PRODUCTION IN THE NORMAL DOG.

Authors:  R STEELE; J S BISHOP; A DUNN; N ALTSZULER; I RATHBEB; R C DEBODO
Journal:  Am J Physiol       Date:  1965-02

2.  Effects of fatty acids, glucagon and anti-insulin serum on the control of gluconeogenesis and ketogenesis in rat liver.

Authors:  J R Williamson
Journal:  Adv Enzyme Regul       Date:  1967

3.  Hormonal control of ketogenesis. Biochemical considerations.

Authors:  J D McGarry; D W Foster
Journal:  Arch Intern Med       Date:  1977-04

4.  Studies in the ketosis of fasting.

Authors:  D W Foster
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

5.  Removal of insulin by perfused rat liver: effect of concentration.

Authors:  C E Mondon; J M Olefsky; C B Dolkas; G M Reaven
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

6.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.

Authors:  P R Bratusch-Marrain; W K Waldhäusl; S Gasić; A Hofer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

7.  Biologic gastric emptying time in diabetic patients, using Tc-99m-labeled resin-oatmeal with and without metoclopramide.

Authors:  P A Domstad; E E Kim; J J Coupal; R Beihn; S Yonts; Y C Choy; P Mandelstam; F H DeLand
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

8.  Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasić; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

9.  Hepatic metabolism of free fatty acids in normal and diabetic dogs.

Authors:  L V Basso; R J Havel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  10 in total

1.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

2.  A study on the hyperinsulinism of late pregnancy.

Authors:  I Piva; G Erle; M Thiella; L Lora; M Strazzabosco; N Sicolo; G Federspil
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

Review 3.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

4.  Changes in OGTT-derived biomarkers in response to lifestyle intervention among Latino adolescents with obesity.

Authors:  Armando Peña; Joon Young Kim; Jessica A Reyes; Kiley B Vander Wyst; Stephanie L Ayers; Micah L Olson; Allison N Williams; Gabriel Q Shaibi
Journal:  Pediatr Obes       Date:  2021-11-03       Impact factor: 4.000

5.  Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.

Authors:  J T Jimenez; S Walford; P D Home; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

6.  Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.

Authors:  D Kelley; A Mitrakou; H Marsh; F Schwenk; J Benn; G Sonnenberg; M Arcangeli; T Aoki; J Sorensen; M Berger
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

Authors:  K S Polonsky; J Licinio-Paixao; B D Given; W Pugh; P Rue; J Galloway; T Karrison; B Frank
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.

Authors:  R Taylor; I Magnusson; D L Rothman; G W Cline; A Caumo; C Cobelli; G I Shulman
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

9.  Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats.

Authors:  Y T Kruszynska; P D Home; K G Alberti
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

10.  Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.